<DOC>
	<DOCNO>NCT01552629</DOCNO>
	<brief_summary>The study assess safety efficacy QGE031 treatment moderate severe atopic dermatitis patient . In addition , QGE031 level blood measure effect QGE031 marker blood skin evaluate . Comparisons effect QGE31 make placebo also cyclosporine , treatment already establish effective atopic dermatitis .</brief_summary>
	<brief_title>A Study Evaluating Safety Efficacy QGE031 Atopic Dermatitis Patients</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Key Inclusion criterion : Male female patient 18 65 year age inclusive ( time screen visit ) , pass screen examination past medical history , physical examination , vital sign , electrocardiogram , laboratory test . Presence atopic dermatitis confirm itchy skin condition past 12 month ( must ) , plus three , , follow : 1 . History involvement skin crease ( front elbow , behind knee , front ankle , around neck around eye ) 2 . Personal history asthma hay fever 3 . History generally dry skin past year 4 . Onset age 2 year 5 . Visible flexural dermatitis Patients EASI score â‰¥20 screen stable AD ( currently experience acute flare AD significant change extent disease treatment regimen month prior enrollment ) Patients Total IgE range 30 5000 IU/mL inclusive Key exclusion criterion : Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive human chorionic gonadotropin ( hCG ) laboratory test Women childbearing potential ( WOCBP ) , define woman physiologically capable become pregnant , include woman whose career , lifestyle , sexual orientation precludes intercourse male partner woman whose partner sterilize vasectomy mean unless use highly effective method birth control : Total abstinence Male/female sterilization Combination two follow ( a+b a+c b+c ) : 1 . Use oral , injected implant hormonal method contraception 2 . Placement intrauterine device ( IUD ) intrauterine system ( IUS ) 3 . Barrier method contraception : condom occlusive cap ( diaphragm cervical/vault cap ) spermicidal foam/gel/film/cream/vaginal suppository</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Atopic dermatitis</keyword>
	<keyword>Atopic eczema</keyword>
	<keyword>Skin Diseases</keyword>
	<keyword>QGE031</keyword>
</DOC>